• Our Members
  • Events
  • Contact us
AMR Industry Alliance
  • About us
    • Why the AMR Industry Alliance?
    • Board Members
  • Shared Goals
    • AMR Industry Declaration
    • Industry Roadmap for Progress on Combating Antimicrobial Resistance
    • Responsible Manufacturing
  • Why AMR?
  • Newsroom
  • Progress Report
  • In Action
Select Page
Abbott (formerly Alere) – Test Target Treat™

Abbott (formerly Alere) – Test Target Treat™

by mcwebmaster | Dec 22, 2017

SIRTURO® (bedaquiline) Development and Launch

SIRTURO® (bedaquiline) Development and Launch

by mcwebmaster | Dec 21, 2017

Merck & Co., Inc – Partnering with Local Hospitals Worldwide to Implement Antimicrobial Stewardship (AMS) Programs

Merck & Co., Inc – Partnering with Local Hospitals Worldwide to Implement Antimicrobial Stewardship (AMS) Programs

by mcwebmaster | Dec 19, 2017

Leveraging global surveillance data to develop rapid diagnostics: MSD & OpGen’s Collaboration

Leveraging global surveillance data to develop rapid diagnostics: MSD & OpGen’s Collaboration

by mcwebmaster | Dec 19, 2017

Johnson & Johnson – Access to diagnostics and therapeutic solutions for TB and MDR-TB (with FIND Diagnostics)

Johnson & Johnson – Access to diagnostics and therapeutic solutions for TB and MDR-TB (with FIND Diagnostics)

by mcwebmaster | Dec 19, 2017

« Older Entries
Next Entries »

stay informed

Subscribe to receive our updates

about us

The AMR Industry Alliance brings together biotech, diagnostics, generics and research-based pharmaceutical companies, to drive and measure industry progress to curb antimicrobial resistance.

read more
contact

AMR Industry Alliance Secretariat (IFPMA)
Chemin des Mines 9
P.O. Box 195
1211 Geneva 20
Switzerland
Email: info@amrindustryalliance.org

© AMR Industry Alliance 2017 - Contact us - Cookies Policy - Privacy Policy - Terms of use - Privacy Centre - Careers